ARCA Biopharma, Inc. - שווי עסקי להכנסות ABIO

ARCA Biopharma Inc (ABIO) - לוגו תאגידי

ARCA Biopharma (ABIO) monetizes the licensing of precision medicine technologies through partnerships with pharmaceutical behemoths. This enterprise value-to-revenue chart visualizes this process, where indicates the current valuation level. The company's success relies on the regulatory approval of Gencaro, while high growth potential is confirmed by the active recruitment of participants for biologic clinical trials.

ABIO יחס שווי פעילות להכנסות ARCA Biopharma, Inc. (04.07.2022 - 20.11.2026)

ARCA Biopharma - פילוחים אנליטיים ומדדי מפתח (ABIO)

- פרטי שווי השוק של המנפיק:
הערכת שווי פונדמנטלית של החברה:ABIO - ARCA Biopharma Inc
מוצר המיוצר על ידי ARCA Bio

Steady demand for innovative developments at ARCA Biopharma (ABIO) renders the business a defensive asset independent of macroeconomic trends. This ratio compares the total enterprise value with sales volume, excluding the impact of leverage to identify the actual market consensus. Analyzing the company's valuation based on revenue, excluding debt, allows for the removal of speculative noise and determines the asset's fundamental attractiveness in the current cycle.